These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25249434)

  • 1. Classification of subpopulations of cells within human primary brain tumors by single cell gene expression profiling.
    Möllerström E; Rydenhag B; Andersson D; Lebkuechner I; Puschmann TB; Chen M; Wilhelmsson U; Ståhlberg A; Malmgren K; Pekny M
    Neurochem Res; 2015 Feb; 40(2):336-52. PubMed ID: 25249434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
    Perry A; Aldape KD; George DH; Burger PC
    Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Loss of heterozygosity of chromosome 1p/19q and p53 protein expression in oligodendroglioma].
    Xiong J; Liu Y; Li C; Zhu JJ; Ye ZR; Mao Y; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):445-50. PubMed ID: 19781190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grade II and III Oligodendroglioma and Astrocytoma.
    van den Bent MJ; Chang SM
    Neurol Clin; 2018 Aug; 36(3):467-484. PubMed ID: 30072066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
    van den Bent MJ; Smits M; Kros JM; Chang SM
    J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations.
    Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T
    J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA expression profiles predict clinical phenotypes in glioma.
    Zhang X; Sun S; Pu JK; Tsang AC; Lee D; Man VO; Lui WM; Wong ST; Leung GK
    Neurobiol Dis; 2012 Oct; 48(1):1-8. PubMed ID: 22709987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Expression of Leptin and Its Receptor During Tumorigenesis of Diffuse Gliomas such as Astrocytoma and Oligodendroglioma- Grade II, III and IV (NOS).
    Vokuda RS; B H S; Madhugiri VS; Velusamy SK; Verma SK
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):479-485. PubMed ID: 30803210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas.
    Cryan JB; Haidar S; Ramkissoon LA; Bi WL; Knoff DS; Schultz N; Abedalthagafi M; Brown L; Wen PY; Reardon DA; Dunn IF; Folkerth RD; Santagata S; Lindeman NI; Ligon AH; Beroukhim R; Hornick JL; Alexander BM; Ligon KL; Ramkissoon SH
    Oncotarget; 2014 Sep; 5(18):8083-92. PubMed ID: 25257301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of 14q chromosome in oligodendroglial and astrocytic tumors.
    Dichamp C; Taillibert S; Aguirre-Cruz L; Lejeune J; Marie Y; Kujas M; Delattre JY; Hoang-Xuan K; Sanson M
    J Neurooncol; 2004 May; 67(3):281-5. PubMed ID: 15164983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pinpointing Cancer Stem Cells in Oligodendroglioma.
    Cancer Discov; 2017 Jan; 7(1):6. PubMed ID: 27864226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic Glioma: Treatment Approaches in the Era of Molecular Diagnostics.
    Ruff MW; Uhm J
    Curr Treat Options Oncol; 2018 Oct; 19(12):61. PubMed ID: 30361986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic oligodendroglioma and oligoastrocytoma.
    van den Bent MJ
    Neurol Clin; 2007 Nov; 25(4):1089-109, ix-x. PubMed ID: 17964027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of S100beta-v-erbB transgenic rats prone to brain tumors].
    Yokoo H; Tanaka Y; Nobusawa S; Nakazato Y; Ohgaki H
    Brain Nerve; 2009 Jul; 61(7):765-72. PubMed ID: 19618853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
    Latysheva A; Emblem KE; Brandal P; Vik-Mo EO; Pahnke J; Røysland K; Hald JK; Server A
    Neuroradiology; 2019 May; 61(5):545-555. PubMed ID: 30712139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendroglioma: impact of molecular biology on its definition, diagnosis and management.
    Ueki K
    Neuropathology; 2005 Sep; 25(3):247-53. PubMed ID: 16193843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.
    Kouwenhoven MC; Gorlia T; Kros JM; Ibdaih A; Brandes AA; Bromberg JE; Mokhtari K; van Duinen SG; Teepen JL; Wesseling P; Vandenbos F; Grisold W; Sipos L; Mirimanoff R; Vecht CJ; Allgeier A; Lacombe D; van den Bent MJ
    Neuro Oncol; 2009 Dec; 11(6):737-46. PubMed ID: 19224764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.